Faculty: Faculty of Life Sciences, School of Cellular and Molecular Medicine. This four-year Master of Science (Integrated Honours) program provides an advanced and in-depth understanding of the biological and immunological principles underlying cancer development, progression, and treatment. It typically builds upon the foundations of a BSc, offering more specialized modules, research opportunities, and advanced techniques in areas such as molecular oncology, tumour immunology, drug discovery, and translational research, preparing graduates for leadership roles in cancer research and related biomedical fields. The program is offered by the School of Cellular and Molecular Medicine within the Faculty of Life Sciences, emphasizing a strong research focus.

Career options in leading roles in cancer research (academia, industry), clinical research management, advanced diagnostics, biotechnology and pharmaceutical companies specializing in oncology, research and development, science leadership, and potentially further study at the PhD level. Graduates from the University of Bristol have a great reputation with employers in the UK, particularly in advanced scientific and healthcare sectors.

The University of Bristol is a member of the UK's prestigious Russell Group, known for its research-intensive universities and high academic standards, with particular strength in life sciences and medicine. It has a great reputation with employers across the UK, especially in advanced scientific and healthcare industries. Located in Bristol, southwest England's largest city and a growing hub for biotech and research, the university offers a dynamic environment with significant opportunities for research collaborations and future employment in cutting-edge biomedical fields. The program's location within the School of Cellular and Molecular Medicine and its MSci designation indicate a strong emphasis on research and advanced study.